Stroke RSS

Filtered By:
Source: Reuters: Health
Drug: Zetia

Filter By:
Specialty
Source
Condition
Cancer
Infectious Disease
Drug
Training
Management
Procedure
Therapy
Vaccine
Nutrition
Country

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

Merck's Zetia cuts heart attack, stroke risk in long-awaited study
CHICAGO (Reuters) - After years of uncertainty, a nearly decade-long study showed that Merck & Co's cholesterol drug Zetia lowered the risk of heart attacks and strokes in high-risk heart patients when used with an effective statin.
Source: Reuters: Health - November 17, 2014 Category: Consumer Health News Tags: healthNews Source Type: news